Publikation:

Synthesis and biological evaluation of novel EG5 inhibitors

Lade...
Vorschaubild

Dateien

Zu diesem Dokument gibt es keine Dateien.

Datum

2005

Autor:innen

Sarli, Vasiliki
Huemmer, Stefan
Sunder-Plassmann, Nils
Giannis, Athanassios

Herausgeber:innen

Kontakt

ISSN der Zeitschrift

Electronic ISSN

ISBN

Bibliografische Daten

Verlag

Schriftenreihe

Auflagebezeichnung

ArXiv-ID

Internationale Patentnummer

Angaben zur Forschungsförderung

Projekt

Open Access-Veröffentlichung
Core Facility der Universität Konstanz

Gesperrt bis

Titel in einer weiteren Sprache

Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published

Erschienen in

ChemBioChem. 2005, 6(11), pp. 2005-2013. ISSN 1439-4227. Available under: doi: 10.1002/cbic.200500168

Zusammenfassung

Human Eg5 is a mitotic kinesin that is essential for bipolar spindle formation and maintenance during mitosis. Recently, the discovery of compounds that inhibit Eg5 and cause mitotic arrest has attracted great interest, due to their potential use as the next generation of antimitotics. Here, we present the synthesis and biological investigation of 3,4-dihydrophenylquinazoline-2(1H)-thiones as selective and potent Eg5 inhibitors.

Zusammenfassung in einer weiteren Sprache

Fachgebiet (DDC)
570 Biowissenschaften, Biologie

Schlagwörter

ab initio calculations, inhibitors, kinesin, mitosis, spindle, small molecule, Eg5, Mitose, Chromosomenbande, Zellteilung

Konferenz

Rezension
undefined / . - undefined, undefined

Forschungsvorhaben

Organisationseinheiten

Zeitschriftenheft

Zugehörige Datensätze in KOPS

Zitieren

ISO 690SARLI, Vasiliki, Stefan HUEMMER, Nils SUNDER-PLASSMANN, Thomas U. MAYER, Athanassios GIANNIS, 2005. Synthesis and biological evaluation of novel EG5 inhibitors. In: ChemBioChem. 2005, 6(11), pp. 2005-2013. ISSN 1439-4227. Available under: doi: 10.1002/cbic.200500168
BibTex
@article{Sarli2005-11Synth-14044,
  year={2005},
  doi={10.1002/cbic.200500168},
  title={Synthesis and biological evaluation of novel EG5 inhibitors},
  number={11},
  volume={6},
  issn={1439-4227},
  journal={ChemBioChem},
  pages={2005--2013},
  author={Sarli, Vasiliki and Huemmer, Stefan and Sunder-Plassmann, Nils and Mayer, Thomas U. and Giannis, Athanassios}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/14044">
    <dc:creator>Mayer, Thomas U.</dc:creator>
    <dcterms:issued>2005-11</dcterms:issued>
    <dcterms:bibliographicCitation>Publ. in: Chembiochem ; 6 (2005), 11. -  S. 2005-2013</dcterms:bibliographicCitation>
    <dcterms:title>Synthesis and biological evaluation of novel EG5 inhibitors</dcterms:title>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2012-01-11T09:20:26Z</dc:date>
    <dc:contributor>Huemmer, Stefan</dc:contributor>
    <dc:creator>Huemmer, Stefan</dc:creator>
    <dc:contributor>Sunder-Plassmann, Nils</dc:contributor>
    <dc:language>eng</dc:language>
    <dc:creator>Giannis, Athanassios</dc:creator>
    <dc:contributor>Mayer, Thomas U.</dc:contributor>
    <dc:contributor>Giannis, Athanassios</dc:contributor>
    <dc:rights>terms-of-use</dc:rights>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/14044"/>
    <dc:contributor>Sarli, Vasiliki</dc:contributor>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2012-01-11T09:20:26Z</dcterms:available>
    <dc:creator>Sarli, Vasiliki</dc:creator>
    <dcterms:abstract xml:lang="eng">Human Eg5 is a mitotic kinesin that is essential for bipolar spindle formation and maintenance during mitosis. Recently, the discovery of compounds that inhibit Eg5 and cause mitotic arrest has attracted great interest, due to their potential use as the next generation of antimitotics. Here, we present the synthesis and biological investigation of 3,4-dihydrophenylquinazoline-2(1H)-thiones as selective and potent Eg5 inhibitors.</dcterms:abstract>
    <dc:creator>Sunder-Plassmann, Nils</dc:creator>
    <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
  </rdf:Description>
</rdf:RDF>

Interner Vermerk

xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter

Kontakt
URL der Originalveröffentl.

Prüfdatum der URL

Prüfungsdatum der Dissertation

Finanzierungsart

Kommentar zur Publikation

Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Nein
Begutachtet
Diese Publikation teilen